(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(-0.93%) $83.07
(-1.16%) $1.619
(-0.38%) $2 338.30
(-0.49%) $27.40
(0.36%) $925.40
(-0.13%) $0.934
(-0.03%) $11.02
(-0.17%) $0.799
(0.00%) $92.17
Live Chart Being Loaded With Signals
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas...
Stats | |
---|---|
本日の出来高 | 64 888.00 |
平均出来高 | 139 020 |
時価総額 | 7.81B |
EPS | $8.09 ( 2023-09-30 ) |
Last Dividend | $0.0547 ( 2021-04-15 ) |
Next Dividend | $0 ( N/A ) |
P/E | 26.14 |
ATR14 | $0.0590 (1.03%) |
ボリューム 相関
M3, Inc. 相関
10 最も正の相関 |
---|
10 最も負の相関 |
---|
知っていましたか?
相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。
相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。
M3, Inc. 相関 - 通貨/商品
M3, Inc. 財務諸表
Annual | 2023 |
収益: | $230.82B |
総利益: | $129.34B (56.04 %) |
EPS: | $72.22 |
FY | 2023 |
収益: | $230.82B |
総利益: | $129.34B (56.04 %) |
EPS: | $72.22 |
FY | 2022 |
収益: | $208.16B |
総利益: | $118.34B (56.85 %) |
EPS: | $94.06 |
FY | 2021 |
収益: | $169.20B |
総利益: | $103.40B (61.11 %) |
EPS: | $27.87 |
Financial Reports:
No articles found.
M3, Inc. Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
First Dividend | $0.0547 | 2021-04-15 |
Last Dividend | $0.0547 | 2021-04-15 |
Next Dividend | $0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 1 | -- |
Total Paid Out | $0.0547 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.3 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 5.00 | |
Div. Directional Score | 7.65 | -- |
Year | Amount | Yield |
---|
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
OVCHY | Ex Dividend Junior | 2023-08-15 | Annually | 0 | 0.00% | |
DURYY | Ex Dividend Junior | 2023-05-15 | Annually | 0 | 0.00% | |
TTNDY | Ex Dividend Knight | 2023-08-28 | Semi-Annually | 0 | 0.00% | |
JMSB | Ex Dividend Junior | 2023-06-26 | Annually | 0 | 0.00% | |
BORT | Ex Dividend Knight | 2023-08-10 | Quarterly | 0 | 0.00% | |
RGPCF | Ex Dividend Junior | 2023-09-01 | Semi-Annually | 0 | 0.00% | |
FBPI | Ex Dividend Knight | 2023-08-30 | Quarterly | 0 | 0.00% | |
VTKLY | Ex Dividend Knight | 2023-07-20 | Semi-Annually | 0 | 0.00% | |
LNVGY | Ex Dividend Knight | 2023-07-26 | Annually | 0 | 0.00% | |
CKHGY | Ex Dividend Knight | 2023-05-11 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.197 | 1.500 | 6.05 | 9.08 | [0 - 0.5] |
returnOnAssetsTTM | 0.1000 | 1.200 | 6.67 | 8.00 | [0 - 0.3] |
returnOnEquityTTM | 0.144 | 1.500 | 9.51 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.278 | -1.000 | 7.22 | -7.22 | [0 - 1] |
currentRatioTTM | 3.95 | 0.800 | 10.00 | 8.00 | [1 - 3] |
quickRatioTTM | 3.82 | 0.800 | 10.00 | 8.00 | [0.8 - 2.5] |
cashRatioTTM | 2.45 | 1.500 | 10.00 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 0.6] |
interestCoverageTTM | 239.46 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 87.40 | 2.00 | 10.00 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 70.80 | 2.00 | 10.00 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0 | -1.500 | 0 | 0 | [0 - 2.5] |
grossProfitMarginTTM | 0.592 | 1.000 | 3.46 | 3.46 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.283 | 1.000 | 6.33 | 6.33 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0 | 1.000 | -1.111 | -1.111 | [0.2 - 2] |
assetTurnoverTTM | 0.506 | 0.800 | 9.96 | 7.97 | [0.5 - 2] |
Total Score | 10.29 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 13.33 | 1.000 | 8.75 | 0 | [1 - 100] |
returnOnEquityTTM | 0.144 | 2.50 | 9.69 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 70.80 | 2.00 | 10.00 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 0 | 1.500 | 0 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 87.40 | 2.00 | 10.00 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.278 | 1.500 | 7.22 | -7.22 | [0 - 1] |
pegRatioTTM | 0.00302 | 1.500 | -3.31 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.253 | 1.000 | 6.18 | 0 | [0.1 - 0.5] |
Total Score | 5.00 |
M3, Inc.
M3, Inc. provides medical-related services primarily to physicians and other healthcare professionals through Internet. The company operates through five reporting segments: Medical Platform, Evidence Solution, Career Solution, Site Solution, and Overseas. It operates m3.com, a members-only Web site for providing information to the healthcare professionals; MR-kun, where member doctors can independently and continuously receive information on the m3com platform; QOL-kun that provides life support information other than medical information to members; AskDoctors, where registered doctors answer questions about health and illness from the general public; MDLinx for medical professionals in the United States; and Doctorsnetuk, a website that provides developing services for pharmaceutical companies, as well as provides drug information database in France, Germany, and Spain. The company also provides career services for doctors and pharmacists through m3com CAREER. In addition, it engages in the sales activities and marketing operations for pharmaceuticals and medical devices; development, sale, and support business of electronic medical records and medical equipment for medical institutions; survey service for medical professionals; sale and marketing support businesses for pharmaceutical companies, etc. through the Internet; provision of management support and consulting services to medical institutions, and home-visit nursing services; and provision of human resources services for healthcare professionals, as well as operates clinical trial facilities. The company was formerly known as So-netM3, Inc. and changed its name to M3, Inc. in January 2010. M3, Inc. was incorporated in 2000 and is headquartered in Tokyo, Japan.
について ライブシグナル
このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。